{"disease":{"id":"human-immunodeficiency-virus-hiv","name":"human immunodeficiency virus hiv"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06604663","title":"Data Science and Qualitative Research for Decision Support in the HIV Care Cascade","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":80000,"lead_sponsor_name":"Brown University","has_results":false},{"nct_id":"NCT07089966","title":"HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":30000,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT07071623","title":"A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":4580,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT07044297","title":"A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":4390,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT05968573","title":"Persuasive Health Communication Intervention for HIV/HCV","phase":"NA","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of South Florida","has_results":false},{"nct_id":"NCT04578145","title":"Community Based Screening for HIV Self Testing in FSW in 23 Priority Districts in Indonesia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1522,"lead_sponsor_name":"Kerti Praja Foundation","has_results":false},{"nct_id":"NCT07418385","title":"Voluntary HIV Screening in the General Population in France","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Université de Reims Champagne-Ardenne","has_results":false},{"nct_id":"NCT04772469","title":"Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men","phase":"NA","overall_status":"COMPLETED","enrollment_count":934,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT03618511","title":"Interventions to Improve HIV Antiretroviral Therapy Adherence","phase":"NA","overall_status":"COMPLETED","enrollment_count":914,"lead_sponsor_name":"University of Michigan","has_results":false},{"nct_id":"NCT03292913","title":"Positive Health Check Evaluation Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":799,"lead_sponsor_name":"RTI International","has_results":true},{"nct_id":"NCT05657106","title":"Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":752,"lead_sponsor_name":"April M Young","has_results":false},{"nct_id":"NCT02403674","title":"Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":734,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01231516","title":"A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":724,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT02831764","title":"An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":722,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT02831673","title":"An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":719,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT02965014","title":"NC Young Women's CoOp","phase":"NA","overall_status":"TERMINATED","enrollment_count":652,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT02484183","title":"CPAP Improving Mortality for Pneumonia in African Children Trial","phase":"NA","overall_status":"TERMINATED","enrollment_count":646,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT02951052","title":"Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":618,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT05452616","title":"Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":610,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT03310515","title":"Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men","phase":"","overall_status":"COMPLETED","enrollment_count":578,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT06035445","title":"Support for Adolescents Living With HIV in South Africa","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":570,"lead_sponsor_name":"Emory University","has_results":false},{"nct_id":"NCT07266831","title":"A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":570,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06598397","title":"Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"New York University","has_results":false},{"nct_id":"NCT01910402","title":"A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":499,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT02037594","title":"Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting","phase":"NA","overall_status":"COMPLETED","enrollment_count":438,"lead_sponsor_name":"Hunter College of City University of New York","has_results":false},{"nct_id":"NCT04122404","title":"POC Strategies to Improve TB Care in Advanced HIV Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":425,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT07209917","title":"Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India","phase":"NA","overall_status":"RECRUITING","enrollment_count":420,"lead_sponsor_name":"University of California, Irvine","has_results":false},{"nct_id":"NCT07039682","title":"Empowering Knowledge, Self-Testing & Resilience Through Innovative Methods for HIV","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Universitas Sebelas Maret","has_results":false},{"nct_id":"NCT03157258","title":"Social Network Intervention to Engage Community PLH to Engage in HIV Medical Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":341,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT01516970","title":"Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":312,"lead_sponsor_name":"Janssen-Cilag G.m.b.H","has_results":true},{"nct_id":"NCT02120352","title":"A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":309,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT04768517","title":"HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT06886971","title":"Strategies to AchieVe Viral Suppression for Youth With HIV","phase":"NA","overall_status":"RECRUITING","enrollment_count":288,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT01448707","title":"A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":274,"lead_sponsor_name":"Janssen-Cilag International NV","has_results":true},{"nct_id":"NCT07370649","title":"Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Pomeranian Medical University Szczecin","has_results":false},{"nct_id":"NCT03577470","title":"An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate","phase":"","overall_status":"COMPLETED","enrollment_count":246,"lead_sponsor_name":"Janssen-Cilag S.p.A.","has_results":false},{"nct_id":"NCT01641809","title":"Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":244,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT00046176","title":"A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT05664802","title":"e-HERO: Ending the HIV Epidemic in Rural Oklahoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Northern Arizona University","has_results":false},{"nct_id":"NCT01536873","title":"Dolutegravir Expanded Access Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT07476339","title":"REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"CAN Community Health","has_results":false},{"nct_id":"NCT06814275","title":"Project neuroARTEMIS","phase":"NA","overall_status":"RECRUITING","enrollment_count":189,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT00044577","title":"New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":166,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT06891066","title":"A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT06880705","title":"The Trans-Led Care Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":124,"lead_sponsor_name":"Illinois Institute of Technology","has_results":false},{"nct_id":"NCT05896761","title":"A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT02741557","title":"Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"ViiV Healthcare","has_results":false},{"nct_id":"NCT02178592","title":"Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":113,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT01803074","title":"Study to Evaluate a HIV Drug for the Treatment of HIV Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"ViiV Healthcare","has_results":true},{"nct_id":"NCT03729778","title":"Impact of HIV-1 and Aging on Mucosal Vaccine Responses","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"VA Eastern Colorado Health Care System","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}